PM
Parametrica Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,221
| Closed | -$570K | – | 31 |
|
|
2023
Q3 | $570K | Sell |
3,221
-7,025
| -69% | -$1.24M | 0.96% | 26 |
|
|
2023
Q2 | $1.95M | Buy |
10,246
+4,293
| +72% | +$815K | 3.75% | 10 |
|
|
2023
Q1 | $1.19M | Sell |
5,953
-3,547
| -37% | -$711K | 2.15% | 17 |
|
|
2022
Q4 | $2.26M | Sell |
9,500
-4,339
| -31% | -$1.03M | 4.63% | 8 |
|
|
2022
Q3 | $2.77M | Buy |
+13,839
| New | +$2.77M | 5.66% | 4 |
|
|
2018
Q4 | – | Sell |
-3,740
| Closed | -$327K | – | 260 |
|
|
2018
Q3 | $327K | Buy |
+3,740
| New | +$327K | 0.72% | 45 |
|
|
2018
Q2 | – | Sell |
-5,928
| Closed | -$706K | – | 59 |
|
|
2018
Q1 | $706K | Buy |
+5,928
| New | +$706K | 0.87% | 16 |
|
|
2016
Q2 | – | Sell |
-3,259
| Closed | -$205K | – | 205 |
|
|
2016
Q1 | $205K | Buy |
+3,259
| New | +$205K | 0.74% | 81 |
|
|
2015
Q4 | – | Sell |
-2,962
| Closed | -$238K | – | 63 |
|
|
2015
Q3 | $238K | Buy |
+2,962
| New | +$238K | 1.5% | 29 |
|